Nicox S.A. (OTCMKTS:NICXF) Short Interest Update

Nicox S.A. (OTCMKTS:NICXF) saw a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 54,900 shares, a decrease of 20.3% from the January 31st total of 68,900 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Nicox Price Performance

Shares of NICXF remained flat at $0.28 during trading hours on Wednesday. The business’s 50 day moving average is $0.24 and its 200-day moving average is $0.33. Nicox has a fifty-two week low of $0.24 and a fifty-two week high of $0.28.

About Nicox

Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.